Kabuki Syndrome Clinical Trial
Official title:
French Kabuki Syndrome Network. Epidemiology, Management of Patients and Research by Array-CGH
Create a census for the duration of the search for French patients with SK
- determining epidemiological and morphological parameters,
- determine the true frequency of clinical symptoms and identify new ones,
- identify complications of the disease to improve the care of patients in the hope of a
better prognosis of the disease and
- performing a radiological study by Voxel based morphometry MRI type (N. BODDAERT,
HOPITAL Necker-Enfants Malades, Paris)
Perform genetic research to identify the genetic bases of SK using CGH-array (Comparative
Genomic Hybridization )
Kabuki syndrome (KS) is a rare syndrome, sporadic dominant condition with a frequency of 1 /
35000 (between 20 and 25 new children by year in France). Five cardinal criteria have been
described for this diagnosis: postnatal growth retardation, mild to moderate mental
retardation, skeletal abnormalities, dermatoglyphic abnormalities and characteristic facial
dysmorphism. Moreover, a large number of other symptoms are described in KS. Each year, new
symptoms are reported in the international literature but without their true frequency or
recommendations for the management of patients. However, these criteria are not always
present in patients and there is no major or minor criteria for establishing the diagnosis.
Nowadays, knowledge of this syndrome is still very fragmentary. At the date of the creation
of the network, no molecular basis has been identified for the SK.
We propose to create a national network of geneticists including 18 centers labeled
"developmental defects" and / or mental retardation in France gathered in Federation
Development Centers labeled anomalies (the FECLAD, Head, Professor A VERLOES, Hospital Robert
Debré, Paris). We will also rely on Kabuki Syndrome Association that gives us logistical
support with families.
The objective of the French Kabuki syndrome network of (FKSN) is to establish a national
network to:
1. create a census for the duration of the search for French patients with SK (expected
number of patients = 110) for
- determining epidemiological and morphological parameters,
- determine the true frequency of clinical symptoms and identify new ones,
- identify complications of the disease to improve the care of patients in the hope
of a better prognosis of the disease and
- performing a radiological study by Voxel based morphometry MRI type (N. BODDAERT,
HOPITAL Necker-Enfants Malades, Paris)
And
2. perform genetic research to identify the genetic bases of SK using CGH-array
(Comparative Genomic Hybridization ).
The RFSK will be responsible for recruiting and evaluating patients with SK, the data
collection and informed consent from patients for participation in the project and the
establishment of rules for management of patients.
We will also perform MRI Voxel based morphometry in a small cohort of 10 patients aged 8 to
15 years to identify abnormal brain region distribution in patients with abnormal SK. The
cohort of patients will be paired with SK-age compared to a historical control cohort and the
cohort of patients with SK will be in uniform after the completion of IQ-type test
WISC-Wechsler Intelligence Scale for Children-IV (tests performed routinely in all center for
each patient).
The RFSK will also be responsible for collecting blood samples with informed consent of
patients for molecular studies. These samples will be centralized in the CRB's Hospital
Necker-Enfants Malades (Head: Prof. CORINNE ANTIGNAC) for the establishment of lymphoblastoid
lines and bases of white blood cells.
Because of the lack of standard methodology of studies of candidate genes relevant in the
rare disease, we will take genetic research, using these samples to identify the genetic
basis of KS using array CGH high density (44000 clones) on an AGILENT platform (Dr. D
SANLAVILLE, Lyon). This research, already used successfully in other sporadic dominant rare
diseases (such as CHARGE syndrome), we may help to identify an anomaly INFRACYTOGENETIQUE to
locate the gene responsible for SK.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03547609 -
Assessment of Memory in Children With Kabuki Syndrom
|
N/A | |
| Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
| Active, not recruiting |
NCT04722315 -
Study of Modified Atkins Diet in Kabuki Syndrome
|
Early Phase 1 |